StockData
SNDL Inc. logo

SNDL Inc. (SNDL) stock

SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2026, year ended Dec 31, 2025Last filing: 40-F on Mar 12, 2026Score 5/30
$1.37−0.02 (-1.44%)

Close on Nov 13, 2026Market cap $360.80MP/E –Yield –

SNDL Inc. grew revenue 2.8% to C$946.40M over fiscal 2026. Free cash flow was C$58.11M, up 25.5% from a year earlier. At the latest close the market valued the company at C$508.95M.

Revenue
C$946.40M
+2.8% vs. a year earlier
Operating income
-C$6.35M
FY2026
Free cash flow
C$58.11M
+25.5% vs. a year earlier
EPS, diluted
-0.06 CAD
FY2026

Key statistics

Valuation at the latest close; fundamentals over fiscal 2026, balances at Dec 31, 2025

Valuation

Market cap
C$508.95M
P/E ratio
–
Price to sales
0.54
Price to book
0.46
Dividend yield
–
Free cash flow yield
11.42%

Fundamentals

Revenue
C$946.40M
Net income
-C$15.77M
EPS, diluted
-0.06 CAD
Free cash flow
C$58.11M

Trading

Previous close
$1.39
Open
$1.38
Day's range
$1.37 – $1.39
Volume
504,978
Average volume (20 days)
1,150,716
Beta (5 years)
1.16
RSI (14 days)
55.3
Volatility (1 year)
52.9%
Relative volume
0.35×
WACC
10.9%

Market cap history

Month-end market cap since 2019, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodSNDLS&P 500DifferenceSNDL per yearS&P 500 per year
1 month+18.1%-3.0%+21.1 pts
3 months+9.6%-2.8%+12.4 pts
Year to date-17.5%+11.5%−29.0 pts
1 year-19.4%+13.5%−32.9 pts
3 years-14.4%+77.7%−92.1 pts-5.0%+21.1%
5 years-85.1%+72.6%−157.7 pts-31.7%+11.5%

Nine years at a glance

Fiscal years 2017 to 2026, CAD

Revenue

C$946.40M+2.8% YoY

Gross profit

C$258.65M+7.6% YoY

Operating income

-C$6.35M

Net income

-C$15.77M

EPS, diluted

-0.06 CAD

Free cash flow

C$58.11M+25.5% YoY
Reported period

Press releases

Releases SNDL filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About SNDL

Medicinal Chemicals & Botanical Products

SNDL Inc., formerly Sundial Growers Inc., is an adult-use cannabis and liquor corporation. The company conducts business across diverse operational segments, comprising liquor retail, cannabis retail, cannabis operations, and investments. Its core activities include the cultivation, harvesting, manufacturing, extraction, and analytical testing of cannabis, alongside wholesale operations and the direct sale of retail cannabis and liquor products. Through its commercial channels, SNDL distributes cannabis to provincial boards as well as retail consumers, while also providing proprietary licensing and operating franchise retail models.

Company profile, executives and history

SNDL stock: common questions

What is SNDL's stock price?

SNDL closed at $1.37 on Nov 13, 2026, down 1.44% on the day.

What is SNDL's market cap?

SNDL was worth $360.80M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is SNDL's P/E ratio?

SNDL lost money over fiscal 2026 (diluted EPS -0.06 CAD), so it has no meaningful P/E ratio.

How much revenue does SNDL make?

SNDL reported revenue of C$946.40M for fiscal 2026, up 2.8% from a year earlier.

Does SNDL pay a dividend?

No. SNDL has not paid a cash dividend over the last twelve months.

How has SNDL stock performed over the past year?

Including dividends, SNDL returned -19.4% over the past year, against +13.5% for the S&P 500.

Who are SNDL's competitors?

Companies most similar to SNDL by business, industry and size include CRLBF, TLRY, TRLV, CURLF, CGC.

See a number that looks wrong?